Literature DB >> 21805638

Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Roger A Moore1, Andrew G Timmes, Phillip A Wilmarth, David Safronetz, Suzette A Priola.   

Abstract

Prion diseases are neurodegenerative disorders associated with the accumulation of an abnormal isoform of the mammalian prion protein (PrP). Fourier transform infrared spectroscopy (FTIR) has previously been used to show that the conformation of aggregated, infectious PrP (PrP(Sc) ) varies between prion strains and these unique conformations may determine strain-specific disease phenotypes. However, the relative amounts of α-helix, β-sheet and other secondary structures have not always been consistent between studies, suggesting that other proteins might be confounding the analysis of PrP(Sc) secondary structure. We have used FTIR and LC-MS/MS to analyze enriched PrP(Sc) from mouse and hamster prion strains both before and after the removal of protein contaminants that commonly co-purify with PrP(Sc) . Our data show that non-PrP proteins do contribute to absorbances that have been associated with α-helical, loop, turn and β-sheet structures attributed to PrP(Sc) . The major contaminant, the α-helical protein ferritin, absorbs strongly at 1652 cm(-1) in the FTIR spectrum associated with PrP(Sc) . However, even the removal of more than 99% of the ferritin from PrP(Sc) did not completely abolish absorbance at 1652 cm(-1) . Our results show that contaminating proteins alter the FTIR spectrum attributed to PrP(Sc) and suggest that the α-helical, loop/turn and β-sheet secondary structure that remains following their removal are derived from PrP(Sc) itself.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805638      PMCID: PMC3727666          DOI: 10.1002/pmic.201100253

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  54 in total

1.  Secondary structural analysis of two recombinant murine proteins, interleukins 1 alpha and 1 beta: is infrared spectroscopy sufficient to assign structure?

Authors:  C L Wilder; A D Friedrich; R O Potts; G O Daumy; M L Francoeur
Journal:  Biochemistry       Date:  1992-01-14       Impact factor: 3.162

2.  Scrapie prion protein contains a phosphatidylinositol glycolipid.

Authors:  N Stahl; D R Borchelt; K Hsiao; S B Prusiner
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

3.  Immunoaffinity purification and neutralization of scrapie prion infectivity.

Authors:  R Gabizon; M P McKinley; D Groth; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy.

Authors:  B W Caughey; A Dong; K S Bhat; D Ernst; S F Hayes; W S Caughey
Journal:  Biochemistry       Date:  1991-08-06       Impact factor: 3.162

5.  Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity.

Authors:  M Gasset; M A Baldwin; R J Fletterick; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

6.  Protein structure by Fourier transform infrared spectroscopy: second derivative spectra.

Authors:  H Susi; D M Byler
Journal:  Biochem Biophys Res Commun       Date:  1983-08-30       Impact factor: 3.575

7.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

8.  Further purification and characterization of scrapie prions.

Authors:  S B Prusiner; D C Bolton; D F Groth; K A Bowman; S P Cochran; M P McKinley
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

9.  The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice.

Authors:  R H Kimberlin; C A Walker; H Fraser
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

10.  The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis.

Authors:  M E Bruce; I McConnell; H Fraser; A G Dickinson
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

View more
  11 in total

Review 1.  Techniques to elucidate the conformation of prions.

Authors:  Martin L Daus
Journal:  World J Biol Chem       Date:  2015-08-26

2.  Cellular prion protein is present in mitochondria of healthy mice.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Brent Race; David W Dorward; Jason R Hollister; Elizabeth R Fischer; Suzette A Priola
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

3.  Cofactor molecules induce structural transformation during infectious prion formation.

Authors:  Michael B Miller; Daphne W Wang; Fei Wang; Geoffrey P Noble; Jiyan Ma; Virgil L Woods; Sheng Li; Surachai Supattapone
Journal:  Structure       Date:  2013-10-10       Impact factor: 5.006

4.  Incongruity between Prion Conversion and Incubation Period following Coinfection.

Authors:  Katie A Langenfeld; Ronald A Shikiya; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  Prion Efficiently Replicates in α-Synuclein Knockout Mice.

Authors:  Edoardo Bistaffa; Martina Rossi; Chiara Maria Giulia De Luca; Federico Cazzaniga; Olga Carletta; Ilaria Campagnani; Fabrizio Tagliavini; Giuseppe Legname; Giorgio Giaccone; Fabio Moda
Journal:  Mol Neurobiol       Date:  2019-04-30       Impact factor: 5.590

Review 6.  Prion Strain Diversity.

Authors:  Jason C Bartz
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

7.  A novel and rapid method for obtaining high titre intact prion strains from mammalian brain.

Authors:  Adam Wenborn; Cassandra Terry; Nathalie Gros; Susan Joiner; Laura D'Castro; Silvia Panico; Jessica Sells; Sabrina Cronier; Jacqueline M Linehan; Sebastian Brandner; Helen R Saibil; John Collinge; Jonathan D F Wadsworth
Journal:  Sci Rep       Date:  2015-05-07       Impact factor: 4.379

8.  Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis.

Authors:  Roger A Moore; Dan E Sturdevant; Bruce Chesebro; Suzette A Priola
Journal:  J Proteome Res       Date:  2014-08-29       Impact factor: 4.466

9.  The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.

Authors:  Roger A Moore; Mark W Head; James W Ironside; Diane L Ritchie; Gianluigi Zanusso; Young Pyo Choi; Young Pyo Choi; Suzette A Priola
Journal:  PLoS Pathog       Date:  2016-02-03       Impact factor: 6.823

10.  Independent amplification of co-infected long incubation period low conversion efficiency prion strains.

Authors:  Thomas E Eckland; Ronald A Shikiya; Jason C Bartz
Journal:  PLoS Pathog       Date:  2018-10-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.